Tokyo Tape
Sign in
← Techmatrix

Quarterly report · Q3

3762.TEDINET S100Q7PI
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥32.3bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥11.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥36.5bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥25.1bn2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥9.0bn2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income¥2.8bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥913m2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥2.4bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥815m2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥2.8bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥893m2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥3.7bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥2.4bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥805m2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥1.6bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥514m2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.6bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥524m2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥1.9bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥614m2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥2.6bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥1.7bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥561m2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥62.2bnat 2022-12-31Cons.Assets IFRS
Total assets¥52.5bnat 2022-03-31Cons.Assets IFRS
Total assets¥43.7bnat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥40.1bnat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥32.3bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥22.1bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥20.2bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥17.2bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥16.4bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥17.5bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥17.0bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥15.6bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥16.3bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥18.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.6bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥2.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥5.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.9bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥2.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥196m2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥1.3bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥1.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥2.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.7bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥39.522022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥12.872022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥59.652021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥39.52021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥13.182021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥39.412022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥12.832022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥59.462021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥39.382021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥13.142021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio28.2%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio32.4%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio35.7%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥349m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥349m
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue2022-04-01 → 2022-12-31¥5.3bn
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue external2022-04-01 → 2022-12-31¥5.2bn
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥116m
jpcrp040300-q3r_E05463-000Application Servicereportable segmentsegment profit2022-04-01 → 2022-12-31−¥166m
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue2022-04-01 → 2022-12-31¥21.2bn
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue external2022-04-01 → 2022-12-31¥21.0bn
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥230m
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentsegment profit2022-04-01 → 2022-12-31¥2.0bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥6.1bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥6.1bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.0bn
—segment totalrevenue2022-04-01 → 2022-12-31¥32.6bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥32.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥349m
—segment totalsegment profit2022-04-01 → 2022-12-31¥2.8bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥260m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥260m
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue2021-04-01 → 2021-12-31¥5.3bn
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue external2021-04-01 → 2021-12-31¥5.2bn
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥57m
jpcrp040300-q3r_E05463-000Application Servicereportable segmentsegment profit2021-04-01 → 2021-12-31−¥50m
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue2021-04-01 → 2021-12-31¥17.8bn
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue external2021-04-01 → 2021-12-31¥17.6bn
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥182m
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentsegment profit2021-04-01 → 2021-12-31¥2.1bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥2.3bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥2.3bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥21m
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥390m
—segment totalrevenue2021-04-01 → 2021-12-31¥25.4bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥25.1bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥260m
—segment totalsegment profit2021-04-01 → 2021-12-31¥2.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 765
ItemContextValueUnit
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-643064000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-1018153000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1YTDDuration－JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSCurrentYTDDuration-248475000JPY
Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control fin cf IFRSPrior1YTDDuration－JPY
Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control fin cf IFRSCurrentYTDDuration1200577000JPY
Other fin cf IFRSPrior1YTDDuration-3243000JPY
Other fin cf IFRSCurrentYTDDuration-7960000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-1651962000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-1044191000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration1511000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration-1654000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration-1037603000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration-1821318000JPY
Cash and cash equivalents IFRSPrior2YearInstant14634332000JPY
Cash and cash equivalents IFRSPrior1YearInstant18155903000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant13596729000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant16334584000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember17604527000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember5193962000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember2299964000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReportableSegmentsMember25098454000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSPrior1YTDDuration25098454000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember181570000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember57296000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember21026000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReportableSegmentsMember259894000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-259894000JPY
Intersegment revenue IFRSPrior1YTDDuration－JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember17786098000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember5251259000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember2320990000JPY
Revenue IFRSPrior1YTDDuration_ReportableSegmentsMember25358348000JPY
Revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-259894000JPY
Revenue IFRSPrior1YTDDuration25098454000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember2076526000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember-50070000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember389559000JPY
Operating profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember2416016000JPY
Operating profit loss IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Operating profit loss IFRSPrior1YTDDuration2416016000JPY
Finance income IFRSPrior1YTDDuration12824000JPY
Finance costs IFRSPrior1YTDDuration24326000JPY
Profit loss before tax IFRSPrior1YTDDuration2404514000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember21017450000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember5151830000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember6116175000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReportableSegmentsMember32285456000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReconcilingItemsMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass